王月,副教授,主要从事表观遗传调控在发育和肿瘤发生发展中的分子机理研究,在DNA复制异常与肿瘤耐药方面取得显著成绩。近年来主持国家自然科学基金青年基金项目1项,中国博士后科学基金面上项目1项,作为课题骨干参与科技部重点研发项目1项,参与国自然面上项目2项。主要成果发表在《Nature Communications》、《Signal Transduction and Targeted Therapy》、《Cancer Cell》等高水平杂志。
教育背景
2014. 9- 2020.7,首都医科大学 |生物化学与分子生物学 | 博士研究生毕业 | 博士学位
2010. 9- 2014.7,新乡医学院 | 生物技术 | 大学本科毕业 | 学士学位
主要工作简历
2023. 4 - 至今,杭州师范大学 | 基础医学院 | 副教授
2021. 4 - 2023.4,北京大学 | 基础医学院 | 博士后
2020. 8 - 2021.4,北京大学 | 基础医学院 | 助理研究员
主持科研项目
1. 国家自然科学基金委员会,青年科学基金项目,FOXN2调控DNA复制及引起基因组不稳定性的机制,2023-01-01 至 2024-12-31,主持,在研。
2. 科研启动经费,DNA复制中的表观遗传调控网络,2023-04至2027-04,主持,在研。
3. 科技部,重点研发计划,肿瘤临床耐药的可塑性调控网络及分子机制,2021-12 至2026-11,课题骨干,在研。
4. 中国博士后科学基金会,FOXN2在子宫内膜癌发生发展中的功能及分子机制研究,2022-11 至 2023-02,主持,已结题。
代表性论著(* corresponding author)
1. Wenting Zhang#, Yue Wang#, Yongjie Liu#, Cuifang Liu, Yizhou Wang, Lin He, Xiao Cheng, Yani Peng, Lu Xia, Xiaodi Wu, Jiajing Wu, Yu Zhang, Luyang Sun, Ping Chen, Guohong Li, Qiang Tu, Jing Liang*, Yongfeng Shang*. NFIB facilitates replication licensing by acting as a genome organizer, Nature Communications. 2023,14(1): 5076-5098.
2. Yue Wang, Yunchao Huang, Edith Cheng, Xinhua Liu, Yu Zhang, Jianguo Yang, Jordan T. F. Young, Grant W. Brown, Xiaohan Yang, Yongfeng Shang*. LSD1 is required for euchromatic origin firing and replication timing, Signal Transduction and Targeted Therapy. 2022, 7(1): 102-118.
3. Yani Peng, Xiaoping Liu, Xinhua Liu, Xiao Cheng, Lu Xia, Leyi Qin, Sudun Guan, Yue Wang, Xiaodi Wu, Jiajing Wu, Dong Yan, Jianying Li, Yu Zhang, Luyang Sun; Jing Liang*, Yongfeng Shang*. RCCD1 promotes breast carcinogenesis through regulating hypoxia-associated mitochondrial homeostasis, Oncogene. 2023, 42(50): 3684-3697.
4. Beibei Liu, Xinhua Liu, Lulu Han, Xing Chen, Xiaodi Wu, Jiajing Wu, Dong Yan, Yue Wang, Shumeng Liu, Lin Shan, Yu Zhang, Yongfeng Shang*. BRD4-directed super-enhancer organization of transcription repression programs links to chemotherapeutic efficacy in breast cancer,PNAS. 2022, 119(6): e2109133119.
5. Zihan Zhang, Xiaoping Liu, Lei Li, Yang Yang, Jianguo Yang, Yue Wang, Jiajing Wu, Xiaodi Wu, Lin Shan, Fei Pei, Jianying Liu, Shu Wang, Wei Li, Luyang Sun, Jing Liang*, Yongfeng Shang*. SNP rs4971059 predisposes to breast carcinogenesis and chemoresistance via TRIM46-mediated HDAC1 degradation,The EMBO journal. 2021, 40(19): e107974.
6. Jianguo Yang, Xiaoping Liu, Yunchao Huang, Lin He, Wenting Zhang, Jie Ren, Yue Wang, Jiajing Wu, Xiaodi Wu, Lin Shan, Xiaohan Yang, Luyang Sun, Jing Liang, Yu Zhang*, Yongfeng Shang*. TRPS1 drives heterochromatic origin refiring and cancer genome evolution,Cell Reports. 2021, 34(10): 108814.
7. Xiaoping Liu, Bosen Xu, Jianguo Yang, Lin He, Zihan Zhang, Xiao Cheng, Huajing Yu, Xujun Liu, Tong Jin, Yani Peng, Yunchao Huang, Lu Xia, Yue Wang, Jiajing Wu, Xiaodi Wu, Shumeng Liu, Lin Shan, Xiaohan Yang, Luyang Sun, Jing Liang, Yu Zhang*, Yongfeng Shang*. UHRF2 commissions the completion of DNA demethylation through allosteric activation by 5hmC and K33-linked ubiquitination of XRCC1,Molecular Cell. 2021, 81(14): 2960-2974.
8. Chao Yang, Jiajing Wu, Xinhua Liu, Yue Wang, Beibei Liu, Xing Chen, Xiaodi Wu, Dong Yan, Lulu Han, Shumeng Liu, Lin Shan, Yongfeng Shang*. Circadian rhythm is disrupted by ZNF704 in breast carcinogenesis, Cancer Research. 2020, 80(19): 4114-4128.
9. Lin He, Xinhua Liu, Jianguo Yang, Wanjin Li, Shumeng Liu, Xujun Liu, Ziran Yang, Jie Ren, Yue Wang, Lin Shan, Chengjian Guan, Fei Pei, Liandi Lei, Yu Zhang, Xia Yi, Xiaohan Yang, Jing Liang, Rong Liu, Luyang Sun*, Yongfeng Shang*. Imbalance of the reciprocally inhibitory loop between the ubiquitin-specific protease USP43 and EGFR/PI3K/AKT drives breast carcinogenesis,Cell Research. 2018, (28): 934-951.
10. Lin Shan, Xing Zhou, Xinhua Liu, Yue Wang, Dongxue Su, Yongqiang Hou, Na Yu, Chao Yang, Beibei Liu, Jie Gao, Yang Duan, Jianguo Yang, Wanjin Li, Jing Liang, Luyang Sun, Kexin Chen, henghao Xuan, Lei Shi, Yan Wang, Yongfeng Shang*. FOXK2 elicits massive transcription repression and suppresses the hypoxic response and breast cancer carcinogenesis,Cancer Cell. 2016, 30(5): 708-722.